Heidelberg
Neurochirurgische Universitätsklinik
Automated and Multiplexed Combinatorial Drug Screening of FDA-Approved Drugs Identifies Potential Synergistic Drug Partners for the Treatment of Aggressive Meningiomas
Successful reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages via GW2580-mediated CSF1R inhibition
Automated and Multiplexed Combinatorial Drug Screening of FDA-Approved Drugs Identifies Potential Synergistic Drug Partners for the Treatment of Aggressive Meningiomas